Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) is a publicly traded Healthcare sector company. As of May 21, 2026, PHAR trades at $12.97 with a market cap of $891.29M and a P/E ratio of 0.00. PHAR moved +0.00% today. Year to date, PHAR is -23.44%; over the trailing twelve months it is +28.70%. Its 52-week range spans $7.31 to $21.34. Analyst consensus is strong buy with an average price target of $38.00. Rallies surfaces PHAR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PHAR moved +0.00% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $12.97 |
| Market Cap | $891.29M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.34 |
| 52-Week Low | $7.31 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover PHAR: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $38.00.